Story thread · 14 reports / 13 sources

First-in-Class Drug Wins FDA Approval for Polycythemia Vera

medpagetoday.com · 14dShare

(MedPage Today) -- The FDA approved first-in-class rusfertide (Mimrylo) for treating erythrocytosis in adults with polycythemia vera (PV), a rare and slow-growing hematologic malignancy. Rusfertide mimics hepcidin, the natural hormone involved...

First report: FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder — fda.gov, 17d